{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:34:43Z","timestamp":1787952883258,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.remnie.2024.500076","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:39:22Z","timestamp":1730273962000},"page":"500076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of staging using [68Ga]Ga-PSMA-11 PET\/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-6186","authenticated-orcid":false,"given":"J.J.","family":"Rosales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Betech Antar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Quincoces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.D.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"P\u00e9rez-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodr\u00edguez-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2024.500076_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.remnie.2024.500076_bib0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.remnie.2024.500076_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2024.500076_bib0020","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00259-023-06278-1","article-title":"Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer","volume":"50","author":"Muehlematter","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of 68 gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.remnie.2024.500076_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2024.500076_bib0035","unstructured":"EAU Guidelines. https:\/\/uroweb.org\/guidelines. [accessed el 8 de octubre de 2024]."},{"key":"10.1016\/j.remnie.2024.500076_bib0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/bju.13573","article-title":"Prediction of pathological stage based on clinical stage, serum prostate\u2010specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era","volume":"119","author":"Tosoian","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.remnie.2024.500076_bib0045","unstructured":"Prostate Cancer Nomograms. https:\/\/www.mskcc.org\/nomograms\/prostate\/pre_op. [accessed el 8 de octubre de 2024]."},{"key":"10.1016\/j.remnie.2024.500076_bib0050","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40658-019-0253-z","article-title":"Multicentre quantitative 68Ga PET\/CT performance harmonisation","volume":"6","author":"Huizing","year":"2019","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.remnie.2024.500076_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","article-title":"EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies","volume":"44","author":"Aide","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0065","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0070","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2016"},{"key":"10.1016\/j.remnie.2024.500076_bib0075","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s00261-019-02006-2","article-title":"68Ga-PSMA-11 PET\/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement","volume":"44","author":"Basha","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.remnie.2024.500076_bib0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14828","article-title":"Risk of metastatic disease on 68 gallium\u2010prostate\u2010specific membrane antigen positron emission tomography computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer","volume":"124","author":"Yaxley","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.remnie.2024.500076_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.21241","article-title":"High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer","volume":"71","author":"Minner","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.remnie.2024.500076_bib0090","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00259-024-06594-0","article-title":"The accuracy and intra- and interobserver variability of PSMA PET\/CT for the local staging of primary prostate cancer","volume":"51","author":"Donswijk","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0095","article-title":"18F-PSMA-1007 PET\/CT performance on risk stratification discrimination and distant metastases prediction in newly diagnosed prostate cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.remnie.2024.500076_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13550-020-00730-1","article-title":"The value of 18F-PSMA-1007 PET\/CT in identifying non-metastatic high-risk prostate cancer","volume":"10","author":"Hong","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.remnie.2024.500076_bib0105","series-title":"Prostate Pathology","author":"Humphrey","year":"2003"},{"key":"10.1016\/j.remnie.2024.500076_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0215(20001220)90:6<305::AID-IJC1>3.0.CO;2-U","article-title":"Patterns of prostate cancer biopsy grading: trends and clinical implications","volume":"90","author":"King","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.remnie.2024.500076_bib0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3389\/fonc.2018.00623","article-title":"Expression of Prostate-Specific Membrane Antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis","volume":"8","author":"Hupe","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.remnie.2024.500076_bib0120","article-title":"[99mTc]Tc-HYNIC-ALUG SPECT\/CT in the initial staging of 227 consecutive patients with newly diagnosed prostate cancer: a 5-year monocentric retrospective study","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.remnie.2024.500076_bib0125","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s00259-018-4037-9","article-title":"68Ga-PSMA-617 PET\/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients","volume":"45","author":"Liu","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5603\/nmr.97424","article-title":"Clinical utility of [68Ga]Ga-PSMA-11 PET\/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values","volume":"27","author":"Rogic","year":"2024","journal-title":"Nucl Med Rev"},{"key":"10.1016\/j.remnie.2024.500076_bib0135","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40644-020-0290-9","article-title":"PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review","volume":"20","author":"Petersen","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.remnie.2024.500076_bib0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"Sonni","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2024.500076_bib0150","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68 Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:27:55Z","timestamp":1740760075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808924001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2253808924001046"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2024.500076","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of staging using [68Ga]Ga-PSMA-11 PET\/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2024.500076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2024.500076","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500076"}}